Pages

Look Towards A New Future

Feb 19, 2013

Platform as a Service (PaaS) Market - By Solutions, Application, Implementation Models, End Users, Industry and Geographies

Most of the companies worldwide are looking at standardizing their operations through cloud computing. In the cloud computing arena PaaS (Platform as a Service) has made its mark in recent years with a subsequent growth. PaaS in cloud computing provides a computing platform and a solution stack, which allows consumers to create software using tools and libraries from the provider. This concept of PaaS is extremely complex to adapt, as establishing a standardized PaaS platform from the scratch is very obscure for organizations. This limitation of cloud portability can now be bypassed through Enterprise PaaS , as it automates customized platform stacks; thereby meeting various application requirements, by working on an on-demand basis.

Considering the expected growth of PaaS users from 3% in the year 2012 to 43% in the year 2015; various companies have ventured into this space. Owing to the foresighted growth potential, PaaS is set to make a mark in the industry and impact the future of the enterprise software market. The PaaS Market research report analyzes the importance of PaaS in the cloud computing industry, its scalability to grow in future, drivers, restraints and challenges in this market. The report also focuses on global trends, evolving platforms and the adoption benefits.

This research report categorizes the global market for PaaS by forecasting the revenues and analyzing the trends in each of the following sub-markets:

Inquire for a discount on this report @ http://www.reportsnreports.com/contacts/Discount.aspx?name=221736.

Based on solutions PaaS market is segmented into four categories.
  • Business application platforms
  • Raw compute Platforms
  • Social application platforms
  • Web application platforms
Based on the Implementation models PaaS market is segmented into three categories.
  • Public cloud
  • Private cloud
  • Hybrid cloud
Based on the Usage the PaaS market is divided in to five categories.
  • Application Development and Maintenance (ADM) PaaS
  • Business Process Management (BPM) PaaS
  • Application PaaS
  • Integration PaaS
  • Other PaaS
Based on the End Users the PaaS market is segmented into two categories.
  • Enterprise
  • Small and Medium size Business
Based on the Geographies the PaaS market is segmented into five categories.
  • North America
  • Europe
  • Asia Pacific
  • Middle East Asia
  • Latin America
Based on the Industry application the PaaS market is segmented into ten categories.
  • Banking & Financial Sector (BFSI)
  • Consumer Goods & Retail
  • Education
  • Gaming
  • Healthcare
  • Logistics & Transportation
  • Public Sector & Government
  • Telecommunications & IT
  • Travel & Hospitality
  • Others
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=221736.

Contact sales@reportsandreports.com for further information.

Global Pharmaceutical Industry Research Report to 2014 - Market Trends, Marketing Spend and Sales Strategies

ICD Research’s industry survey reveals that, overall, the marketing budgets of global pharmaceutical industry suppliers’ are expected to increase by 8% in 2013, while the increase in budgets was 6% in 2012, 7.7% in 2011, and 3.9% in 2010. As the average marketing budget among respondents is projected at US$2.6 million2, the average budget increase among respondents is expected to be US$208,000. Survey results show that 75% of respondents expect at least some increase in their marketing budget, while 13% of respondents project ‘no change’ in their marketing budget. Factors such as new product launches, a rise in R&D expenditure, business expansion to new markets, and to build brand awareness are some of the major reasons for this expected increase.

A comparison of global marketing budgets by operating region shows that global pharmaceutical industry supplier respondents from companies in Asia-Pacific have the highest average budget, of US$6.5 million, in 2013. They are followed by respondents from companies that primarily operate in North America, with an average budget of US$3.4 million, and respondents from companies that primarily operate in Europe, with an average budget of US$700,000. Finally, respondents from companies that primarily operate in the Rest of the World region expect the lowest average marketing budget of US$300,000.


Contact sales@reportsandreports.com for further information.

A comparison of global marketing budgets by company turnover shows that, in 2013, pharmaceutical industry supplier respondents from large companies have an average marketing budget of US$11.4 million available to them. Respondents from medium-sized companies have an average marketing budget of US$1.2 million, whereas respondents from small companies have an average marketing budget of US$400,000 in 2013.

While 97% of respondents from small companies have marketing budgets of less than US$250,000, 25% and 27% of respondents from medium-sized and large companies, respectively, have marketing budgets between US$250,000–US$1 million to spend in 2013.

Contact sales@reportsandreports.com for further information.

Feb 16, 2013

France Soft Drinks Market Research Report

ReportsnReports adds new market research report "France Soft Drinks Review 2012" to its store.

Synopsis
A competitively priced comprehensive overview of the key categories in the soft drinks market.

Why was the report written?
Soft Drinks Review 2012 reports provide a comprehensive overview of soft drinks markets. Compiled from Canadean’s extensive global soft drinks database, the reports offer a cost effective way of quickly gaining an understanding of the industries dynamics and structure.

What is the current market landscape and what is changing?
Current economic environment remains gloomy in western markets and Eurozone countries are having a particularly turbulent ride.

What are the key drivers behind recent market changes?
Soft drinks growth in developing market continues to be boosted by an expanding consumer base and rising disposable income levels. In developed markets there is a trend towards natural and local products.

What makes this report unique and essential to read?
The 2012 Soft Drinks Review reports comprise of data tables, charts and supporting text. The reports are compiled from Canadean’s extensive global soft drinks databases which are researched individually by country using our specialist researchers ‘on the ground’. Soft Drinks Reviews provide an invaluable guide to latest trends.

Inquire for a discount on this report @ http://www.reportsnreports.com/contacts/Discount.aspx?name=219532.

Scope
Data includes consumption volumes (million litres & litres per capita) for key soft drinks categories from 2006 to 2011 plus forecasts to 2015.
Percentage markets shares are provided for key soft drinks categories including segmentation data, packaging data and distribution (2010 and 2011 actuals, plus 2012 forecasts.
Leading companies’ market shares for 2010 and 2011 are provided by soft drinks category.
A market valuation is provided for each soft drinks category and, where applicable, new products in 2011 are identified.
Supporting text includes commentary on current and emerging trends, segmentation, packaging, distribution, pricing/valuation and where applicable, functional products and private label.

Reasons To Buy
Global economic turbulence affects soft drinks market as consumer purchasing power remains low in many markets.
Rising commodity costs are leading some producers to look at ways at lowering costs, e.g. by producing lower juice content drinks.
Consumer environmental concerns affecting beverage choices such as packaged water.
Price promotions and marketing activity were strongly in evidence towards the end of 2012 in Europe and this is expected to continue in to 2013. The climate of heavy promotional activity is expected to raise pressure on Private Label brands and producers.
Key sporting events in 2012 such as the London Olympic Games and UEFA Championships provide an opportunity for soft drinks.

Key Highlights
Innovation keeps energy growth lively, with the flavours and packs emerging.
Juice, nectars and still drinks affected by formulation changes as producers look to reduce costs by lowering juice content.
Low-priced packaged water fuels growth in emerging markets.
Key sports events an opportunity for soft drinks, in particular soft drinks.
Local-source products becoming more prominent as consumers favour ‘home-grown’ products.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=219532.

Contact sales@reportsandreports.com for further information.

Feb 7, 2013

Poland HNWI Asset Allocation and Forecasts for 2017

This report is the result of WealthInsight’s extensive research covering the high net worth individual (HNWI) population and wealth management market in Poland.

Summary
This report provides the latest asset allocations of Polish HNWIs across 13 asset classes. The report also includes projections of the volume, wealth and asset allocation of Polish HNWIs to 2017 and a comprehensive and robust background of the local economy.

Scope
Independent market sizing of Polish HNWIs across five wealth bands
HNWI volume, wealth and allocation trends from 2007 to 2012
HNWI volume, wealth and allocation forecasts to 2017
HNWI and UHNWI asset allocations across 13 asset classes
Insights into the drivers of HNWI wealth

Reasons To Buy
The WealthInsight Intelligence Center Database is an unparalleled resource and the leading resource of its kind. Compiled and curated by a team of expert research specialists, the Database comprises profiles on major private banks, wealth managers and family offices in each country.
The WealthInsight Intelligence Center Database also includes up to one hundred data-points on over 100,000 HNWIs from around the world.
With the Database as the foundation for our research and analysis, we are able obtain an unsurpassed level of granularity, insight and authority on the HNWI and wealth management universe in each of the countries and regions we cover.
Report includes comprehensive forecasts to 2017.

Key Highlights
There are just over 28,400 HNWIs in Poland in 2012. These HNWIs hold US$139 billion in wealth which equates to 16% of total individual wealth held in the country.
In 2012, equities were the largest asset class for HNWIs in Poland (31% of total HNWI assets), followed by business interests (24.8%), real estate (19.0%), fixed income (14.3%), cash (6.8%) and alternatives (4.6%).
Business interest and fixed-income products recorded the strongest growth over the review period, driven by new business formation and a movement to safer asset classes. Equities and real estate registered the weakest performance.
Over the forecast period, alternatives are expected to be the top-performing asset class for HNWIs, followed by equities and real estate. As a result, there will be a movement away from cash and towards alternatives.
As of 2012, HNWI liquid assets amounted to US$23 billion, representing approximately 16.3% of the wealth holdings of Polish HNWIs.
WealthInsight’s research showed that in 2012, 36% of Polish HNWIs have second homes abroad. The largest destinations for these homes include Geneva, Zurich, Paris and London.
At the end of 2012, Polish HNWIs held 30.6% (US$42 billion) of their wealth outside of Poland, which is well above the norm for worldwide HNWIs of between 20% and 30%.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218695.

Contact sales@reportsandreports.com for further information.

Central and Eastern Europe Medical Devices Industry Research Report

The countries of Central and Eastern Europe represented a total market of 302 million people and a combined GDP of US$3.3 trillion in 2012.

Central & Eastern Europe is composed of a diverse range of markets, all at different stages of development. Markets throughout the region grew very rapidly until 2008, as many countries joined the EU between 2004 and 2007. All have healthcare systems in great need of renovation and updating, and spending on new diagnostic equipment in particular has been very strong. Most new equipment is imported, as Russia, Poland, the Czech Republic, Ukraine and Hungary represent the five largest markets in the region. Slovenia is a small market, but has the highest per capita expenditure, on a par with much of Western Europe.

The Economic Situation
All countries in the CEE region were affected by the global economic crisis to some extent; Ukraine was particularly hard hit with its economy contracting by 14.8% in 2009. However, most of the region emerged from recession in 2010 and all CEE countries were exhibiting positive growth rates by 2011. The regional economy is expected to grow by an annual average of 3.1% between 2012 and 2016, although the ongoing eurozone crisis may negatively impact this rate. The CEE region contains export-dependent countries such as the Czech Republic and Hungary, which will be vulnerable to any depressed demand in the eurozone. However, financial assistance provided by the IMF has helped countries such as Romania to strengthen their economies and limit the effects of the recession on the health sector; overall demand for medical devices has therefore remained strong, particularly in the consumables field.

Regional Health Expenditure
Total health expenditure for the CEE region is projected to reach an estimated US$329.0 billion by 2016, equal to 6.7% of GDP. At present, only 29% of spending in the region is private, but over 85% of this is composed of out-of-pocket payments. The area of private healthcare plans remains largely undeveloped within most markets. Slovenia, the wealthiest country per capita in the region, is the only state in which private plans have become a strong feature, representing almost half of total private spending.

Focus on market opportunities: Diagnostic Imaging
The table below shows the rise in demand for imported diagnostic imaging equipment since the end of the economic crisis, following a period of slow-moderate growth. Between 2006 and 2010, the CAGR for such equipment did not exceed 20% in the countries listed below; however, import performance was much more encouraging in the year ending October 2011, particularly in Romania and Poland where growth rates reached 47.8% and 34.0%, respectively. Only modest growth was observed in the Czech Republic and Slovakia, however. It will take time for countries such as Ukraine to return to pre-crisis growth rates; renewed investment in high-tech equipment will ensue as their economies strengthen.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=53537.

Highlights from the region

CZECH REPUBLIC
The Czech Republic was one of the larger and richer former Soviet countries to join the EU in May 2004. Its regulation and trade rules are now generally aligned to EU standards. It is well-located in central Europe and has an estimated population of 10.5 million in 2011. Healthcare funding is largely public, and mainly through health insurance. Private spending only accounts for an estimated 16.6% of total health expenditure in 2011. Provision of care is also largely public; the Czech Republic has yet to develop a substantial private sector. Around 80% of the Czech Republic medical device market is supplied by imports, which have risen rapidly in the past decade. In 2011, 35.7% were sourced from Germany. Other major suppliers were the Netherlands, Belgium, Switzerland and France. In 2011, imports rose by 6.6% over 2010 and by a 2007-2011 CAGR of 8.2%.

HUNGARY
In 2011, the Hungarian market for medical equipment and supplies is estimated at US$573 million, or US$58 per capita. The market value has stalled since 2008, but it is expected that it will bounce back to expand at a CAGR of 4.5% per annum in the 2011-16 period, reaching US$715 million by 2016, equal to US$73 per capita.
Around 84% of the medical device market is supplied by imports. Most are sourced from the European Union, principally the Netherlands and Germany. There is a sizeable domestic production sector, with X-ray apparatus as a particular historic specialty, but this is largely geared towards export markets.

POLAND
The size of the private healthcare sector is slowly expanding. The availability of private facilities improved significantly in 2000, when bed numbers increased three-fold. Around a quarter of health expenditure is private, although out-of-pocket payments account for most of this. In 2011, the Polish market for medical equipment and supplies is estimated at US$2,013.4 million, or US$53 per capita. The market experienced rapid growth until the end of 2008, but imports fell back sharply in the early part of 2009. The economic downturn has so far proved short, however, with growth resuming in 2010, albeit at a slightly lower rate than in previous years. Around 85% of the Polish medical device market is supplied by imports. Germany and the Netherlands were the leading suppliers in 2011, together accounting for around nearly half of imports. Germany was the leading supplier of most categories of medical equipment.

RUSSIA
The Russian medical market is potentially huge, given its population and potential wealth of natural resources. Health expenditure remains low however, and patients are often forced to rely on out-of-pocket payments for treatment. A system of medical insurance is in place, but it is badly managed and the quality of treatment varies from region to region. The Russian healthcare system retains many of its Soviet-era characteristics, remaining bureaucratic and inefficient. However, the government’s national ‘health’ project aims to improve healthcare standards. Since the project’s implementation, numerous medical facilities have been upgraded and a substantial number of medical personnel have been awarded salary increases. In 2011, the Russian market for medical equipment and supplies is estimated at US$5,961.3 million. Per capita spending is low by European standards at US$42 per capita. This is despite rapid growth, especially of imported products, in the 2006-08 period.

11 Key Markets Covered
Bulgaria
Croatia
Czech Republic
Hungary
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Ukraine

Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=53537.

Contact sales@reportsandreports.com for further information.